Injective (INJ)USD

$7.36

Custom

Key Statistics

Market Cap$735.90M
FDV$735.90M
24h Volume$13.59M
24h Low$7.27
24h High$7.80
Circulating Supply100,000,000 INJ
Max SupplyNo hard capTotal 100,000,000 INJ
All-Time High$52.62-85.8% from ATH
Data provided by CoinGecko

About Injective

Injective is a Layer 1 blockchain built for finance, providing infrastructure for decentralized exchanges, derivatives, lending, prediction markets, and other financial applications. Eric Chen and Albert Chon founded Injective Labs in 2018. The project was incubated through Binance Labs, and the Injective Chain with its native token launched on November 8, 2021. The network uses a Tendermint-based proof-of-stake consensus mechanism that delivers sub-second finality and supports over 25,000 transactions per second. Its native token, INJ, is used to stake and secure the network, pay transaction fees, and vote on governance proposals. The protocol runs a buy-back-and-burn auction mechanism that uses protocol revenue to purchase and permanently remove INJ from circulation, creating deflationary pressure. Staking rewards can mint new tokens, and while earlier figures described a hard cap near 100 million INJ, the total supply has since exceeded that level and is not fixed at a firm ceiling today. Developers can deploy DeFi applications on Injective across spot and derivatives trading, lending, and related services.

Injective launches first-ever Stockdrop for tokenized stocks this week

Injective's Stockdrop could revolutionize equity access, offering decentralized, 24/7 trading and potentially reshaping traditional markets.

By ESTEFANO GOMEZ

Injective Meridian mainnet upgrade proposal passes with 99% support

The Meridian upgrade positions Injective as a compliance-native blockchain, potentially boosting institutional adoption and INJ token demand.

By EDITORIAL TEAM

Injective partners with Microsoft to host onchain commerce event ahead of Token2049

Injective's collaboration with Microsoft could accelerate AI-blockchain integration, potentially transforming digital commerce and financial systems.

By EDITORIAL TEAM

SEC receives amended S-1/A filing for 21Shares Injective ETF as altcoin ETF race heats up

The SEC's review of the 21Shares Injective ETF could accelerate mainstream adoption of altcoins, impacting market dynamics and investor strategies.

By EDITORIAL TEAM

Jupiter Exchange enables INJ swaps for SOL and SPL tokens

The integration enhances cross-chain liquidity and trading efficiency, potentially boosting Solana's ecosystem and Injective's market reach.

By EDITORIAL TEAM

Injective Protocol’s INJ token goes live on Solana via Sunrise and Backpack Securities

The INJ token's integration into Solana enhances multi-chain accessibility, fostering innovation and liquidity in decentralized finance ecosystems.

By EDITORIAL TEAM